AZZI, ALBERTA
 Distribuzione geografica
Continente #
NA - Nord America 7.461
EU - Europa 4.528
AS - Asia 2.285
SA - Sud America 318
OC - Oceania 89
AF - Africa 60
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.742
Nazione #
US - Stati Uniti d'America 7.411
RU - Federazione Russa 1.719
PL - Polonia 805
SG - Singapore 708
HK - Hong Kong 491
CN - Cina 470
SE - Svezia 459
IE - Irlanda 455
IT - Italia 384
BR - Brasile 256
KR - Corea 255
UA - Ucraina 207
DE - Germania 173
FI - Finlandia 130
AU - Australia 86
IN - India 86
GB - Regno Unito 80
VN - Vietnam 78
JO - Giordania 69
CI - Costa d'Avorio 37
FR - Francia 31
TR - Turchia 28
CA - Canada 27
AR - Argentina 20
BD - Bangladesh 17
CH - Svizzera 16
MX - Messico 16
AT - Austria 15
ID - Indonesia 14
NL - Olanda 14
CO - Colombia 10
IQ - Iraq 10
PY - Paraguay 9
VE - Venezuela 8
BE - Belgio 7
EC - Ecuador 7
PK - Pakistan 7
SA - Arabia Saudita 7
ES - Italia 6
JP - Giappone 6
SC - Seychelles 5
AZ - Azerbaigian 4
LT - Lituania 4
MA - Marocco 4
PH - Filippine 4
TN - Tunisia 4
TW - Taiwan 4
UY - Uruguay 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EE - Estonia 3
EG - Egitto 3
IL - Israele 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PE - Perù 3
SM - San Marino 3
TT - Trinidad e Tobago 3
AL - Albania 2
BY - Bielorussia 2
DK - Danimarca 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
CL - Cile 1
CR - Costa Rica 1
GT - Guatemala 1
LB - Libano 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 14.742
Città #
Santa Clara 1.907
Warsaw 804
Fairfield 701
Ashburn 525
Chandler 513
Singapore 477
Dublin 454
Hong Kong 394
Woodbridge 335
Jacksonville 322
Cambridge 292
Houston 256
Seattle 255
Seoul 254
Wilmington 201
Beijing 178
Princeton 126
Ann Arbor 120
Buffalo 105
Dallas 91
Melbourne 84
Boston 76
Kent 76
Mumbai 76
Los Angeles 72
Florence 71
Hefei 69
Medford 66
Boardman 58
The Dalles 58
Altamura 48
Munich 46
Lawrence 45
Moscow 43
Abidjan 37
San Diego 34
Milan 32
Shanghai 30
Ho Chi Minh City 29
Redondo Beach 28
São Paulo 28
Norwalk 27
Izmir 20
Rome 19
New York 17
Council Bluffs 16
Wayne 16
Vienna 15
London 14
Brooklyn 13
Toronto 13
Hillsboro 12
Rio de Janeiro 12
Tianjin 11
Andover 10
Saint Petersburg 10
Turku 10
Hanoi 9
Phoenix 9
Clifton 8
Dong Ket 8
Falls Church 8
Bari 7
Brussels 7
Jakarta 7
Sesto Fiorentino 7
Stockholm 7
Atlanta 6
Belo Horizonte 6
Brescia 6
Frankfurt Am Main 6
Laurel 6
Tokyo 6
Yubileyny 6
Chicago 5
Denver 5
Guarulhos 5
Montreal 5
Paris 5
Porto Alegre 5
Romano di Lombardia 5
San Francisco 5
Ancona 4
Asunción 4
Baghdad 4
Baku 4
Bern 4
Brasília 4
Campinas 4
Colombo 4
Dhaka 4
Elk Grove Village 4
Frankfurt am Main 4
Guangzhou 4
Helsinki 4
Hải Dương 4
Montevideo 4
Orem 4
Ottawa 4
San Giovanni Valdarno 4
Totale 9.882
Nome #
H3N2 Virus as Causative Agent of ARDS Requiring Extracorporeal Membrane Oxygenation Support 319
Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. 316
Molecular markers of influenza B lineages and clades 305
Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy. 296
Human parvovirus PARV4 DNA in tissues from adult individuals: a comparison with human parvovirus B19 (B19V). 283
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center 253
Artrite reumatoide e parvovirus B19: osservazioni preliminari 230
A real-time reverse transcriptase-polymer chain reaction to evaluate natural history of viral shedding in outpatient children and adolescents with pandemic 2009 influenza A(H1N1). 184
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 184
Human herpesviruses respiratory infections in patients with acute respiratory distress (ARDS) 183
CONFUTAZIONE DI RECENTI IPOTESI ETIOLOGICHE PER LA PITIRIASI ROSEA DI GIBERT. 179
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 178
Detection of JCPyV microRNA in blood and urine samples of multiple sclerosis patients under natalizumab therapy. 174
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis. 172
Human parvovirus B19 experimental infection in human fibroblasts and endothelial cells cultures. 168
Tissue persistence of parvovirus B19 genotypes in asymptomatic persons 167
Characterization of human H1N1 influenza virus variants selected In vitro with zanamivir in the presence of sialic acid-containing molecules 163
Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules. 163
The JCPYV DNA load inversely correlates with the viral microrna expression in blood and cerebrospinal fluid of patients at risk of PML 161
Human parvovirus B19 (B19V) infection in systemic sclerosis patients. 161
Comparison of in vitro replication features of H7N3 influenza viruses from wild ducks and turkeys: potential implications for interspecies transmission. 159
A FRET based melting curve analysis to detect nucleotide variations in HA receptor-binding site of H5N1 virus. 157
Effectiveness of nanofiltration in removing small non-enveloped viruses from three different plasma-derived products. 157
Molecular surveillance of pandemic influenza A(H1N1) viruses circulating in Italy from May 2009 to February 2010: association between haemagglutinin mutations and clinical outcome. 155
Reassortment ability of the 2009 pandemic H1N1 influenza virus with circulating human and avian influenza viruses: Public health risk implications 154
HA222 polymorphism in Influenza A(H1N1) 2009 isolates from Intensive Care Units and ambulatory patients during three influenza seasons. 154
Different behavior of erythrovirus B19 and torquetenovirus in response to a single step of albumin purification. 153
PRESENCE OF TT VIRUS (TTV) DNA IN BONE MARROW CELLS FROM HAEMATOLOGIC PATIENTS 150
Human polyomaviruses DNA detection in peripheral blood leukocytes from immunocompetent and immunocompromised individuals 148
High resolution melting analysis as a tool to detect molecular markers of antiviral resistance in influenza A viruses. 147
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. 146
Archetypal and rearranged sequences of human polyomavirus JC transcription control region in peripheral blood leukocytes and in cerebrospinal fluid. 146
BK virus regulatory region sequence deletions in a case of human polyomavirus associated nephropathy (PVAN) after kidney transplantation. 146
Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients. 146
Inter-laboratory comparison of qualitative and quantitative detection of hepatitis C (HCV) virus RNA in diagnostic virology: a multicentre study (MS) in Italy. 146
Human parvovirus B19 infection in bone marrow transplantation patients 143
Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. 138
Human herpesvirus 8 (HHV-8) DNA sequences are present in bone marrow from HIV-negative patients with lymphoproliferative disorders and from healthy blood donors. 135
Human parvovirus B19 in clotting factor concentrates: B19 DNA detection by nested polymerase chain reaction 135
Typing of European strains of parvovirus B19 by restriction endonuclease analyses and sequencing: identification of evolutionary lineages and evidence of recombination of markers from different lineages. 132
Cryptococcose disséminée chez le chat. 131
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients 130
Polyomavirus BK-specific immunity after kidney transplantation. 129
No association between human parvovirus B19 infection and Sjogren's syndrome. 129
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. 129
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 128
Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host. 128
Cryptococcose chez le chien: deux cas cliniques. 126
aplastic crisis caused by B19 virus in a child during induction therapy for acute lymphoblastic leukemia 126
Human parvovirus B19 infection within a family and risk for pregnant women 126
Cutaneous vasculitis due to human parvovirus B19 in an HIV-infected patient: report of a case. 125
TT virus contaminates first-generation recombinant factor VIII concentrates. 124
Detection of B19 parvovirus infections by dot-blot hybridization assay using a digoxigenin-labelled probe 122
Analisi dell’espressione di microRNA prodotti dal Polyomavirus JC. 122
Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. 120
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. 119
Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis 119
BKV e HPV nel sarcoma di Kaposi (KS) AIDS correlate 118
Cryptococcus infection in immunodepressed subjects 118
Lymphocytopenia as a marker for pandemic influenza A/H1N1 2009 virus infection in children. 117
Small RNAs targeting the 5' end of the viral polymerase gene segments specifically interfere with influenza type A virus replication 117
Inchiesta sulla diffusione della criptococcosi nei portatori di HIV in Italia 115
Sequential vidarabine infusion in the treatment of polyoma virus-associated acute haemorrhagic cystitis late after allogeneic bone marrow transplantation. 114
Parvovirus B19 and systemic sclerosis. 111
I segnali di packaging alle estremità 5’ della regione codificante dei geni PA, PB1, E PB2 del virus dell’influenza come potenziali bersagli per lo sviluppo di antivirali. 111
Isolation of influenza A(H3N2) virus with "O"-->"D" phase variation. 109
Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients 109
Multicentre Italian Study Group (MISG) for the standardisation of hepatitis C virus (HCV) PCR. 108
Persistent parvovirus B19 infections with different clinical outcomes in renal transplant recipients: diagnostic relevance of polymerase chain reaction (PCR) and of quantification of B19 DNA in sera 108
Human parvovirus B19 infection in hemophiliacs first infused with two high-purity, virally attenuated Factor VIII concentrate 108
Parvovirus B19 infection in cultured skin fibroblasts from systemic sclerosis patients: a comment on the article of Ray et al. 108
INTRAUTERINE PARVOVIRUS B19 INFECTION: EARLY PRENATAL DIAGNOSIS IS POSSIBLE. 106
Parvovirus B19 infection of bone marrow in systemic sclerosis patients 106
Cytopenia caused by parvovirus in adult ALL patient 106
Indagine epidemiologica sull'infezione da parvovirus B19 in diverse categorie 106
The transfusion-associated transmission of parvovirus B19. 105
Use of denaturing gradient gel electrophoresis for human polyomavirus JC sequence analysis. 104
Increased pathogenicity and shedding in chickens of a wild bird origin LPAI virus of the H7N3 subtype following multiple in vivo passages in quail and turkey. 104
Polymerase chain reaction for synthesis of digoxigenin-labelled DNA probe: application to parvovirus B19 and to polyomavirus BK 103
Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: successful outcome without original allograft nephrectomy. 103
NO ASSOCIATION BETWEEN HUMAN PARVOVIRUS B19 INFECTION AND SJÖGREN¿S SINDROME. 101
BK and JC viruses 99
In vitro and ex vivo detection of human polyomavirus JC microRNA 99
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. 99
Unusual incidence of aplastic Anaemia due to B19 parvovirus infection in renal transplant recipients 99
Severe aplastic anaemia due to B19 parvovirus infection in renal transpalnt recipient 97
Packaging signals in the 5' coding region of influenza virus PA, PB1, and PB2 genes as potential target to develop oligonucleotide based antiviral molecole. 97
Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: an approach to assess the relationship between BK viruria and hemorrhagic cystitis. 96
Letter to Editor: Hypoplastic anemia in a hemophiliac first infused with a solvent/detergent treated Factor VIII concentrate: the role of human B19 parvovirus 96
Development of a Quantitative Competitive Polymerase Chain Reaction for Human Polyomavirus BK 96
Parvovirus B19 and systemic sclerosis 95
Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow tranplantation patients 93
Sorveglianza delle infezioni fungine nelle leucemie acute. 93
First-generation recombinant factor VIII concentratesare free from viral contaminations? 87
Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy. 86
Sonda marcata con digossigenina per la ricerca di BKV 86
Parvovirus B19 infection in a patient with cutaneous vasculitis, arthralgia and paresthesia 84
Hemorrahagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia 81
New influenza virus type A (H1N1), isolated in Florence. 80
Trasmissibilità dell'infezione da parvovirus B19 attraverso il sangue e gli emoderivati 80
Totale 13.677
Categoria #
all - tutte 37.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021616 0 0 0 0 0 150 29 82 81 135 62 77
2021/2022619 18 69 15 21 33 31 15 33 43 27 106 208
2022/20231.908 224 226 89 140 163 399 265 100 213 16 51 22
2023/2024617 37 84 123 23 34 32 24 94 9 33 83 41
2024/20254.923 168 551 311 717 1.436 900 61 272 201 74 148 84
2025/20262.370 571 626 351 240 547 35 0 0 0 0 0 0
Totale 14.804